Lion's Mane for Eye Health: What the Early Research Actually Shows

By Peter Orpen · Updated: March 2026 · Evidence Grade: Preliminary

Eye health is one of the least-discussed areas of lion's mane (Hericium erinaceus) research. You will not find it in most listicles. But there is a scientific reason this mushroom is of interest to vision researchers — and it starts with one anatomical fact: the optic nerve is, fundamentally, part of the central nervous system.

Lion's mane's primary and most substantial evidence base is neuroprotection — stimulating nerve growth factor (NGF), protecting neurons from oxidative damage, supporting the repair of neural tissue. The optic nerve and retina are neural tissue. The logical connection is there. But how far does the evidence actually extend to the eye specifically?

Not as far as many content pieces would have you believe. This article will tell you exactly what the research shows, what it does not show, and where the critical gaps are — including one important limitation about our own product that you deserve to know upfront.

Why the Optic Nerve Makes Lion's Mane Relevant to Eye Health

To understand why researchers are interested in lion's mane and eye health, you need to understand the anatomy of vision. The retina is not merely a light-sensitive membrane — it is an extension of the brain. Retinal ganglion cells (RGCs) are neurons. The optic nerve that connects your eye to your visual cortex is a nerve tract, classified as cranial nerve II, and it is considered part of the central nervous system (CNS) rather than the peripheral nervous system.

This matters because lion's mane's most documented bioactivity — stimulation of nerve growth factor (NGF) synthesis — is relevant to CNS neurons broadly, not just the brain. NGF is a protein that promotes the survival, maintenance, and regeneration of neurons. The classic work of Kawagishi and colleagues established that hericenones (from the fruiting body) and erinacines (from the mycelium) both stimulate NGF synthesis, though via different mechanisms and at different sites in the body.

Research has confirmed that NGF is expressed in ocular tissue, including the retina and optic nerve. NGF administration has shown protective effects on RGCs in experimental models. This is the conceptual foundation on which the eye-and-lion's-mane hypothesis rests — but it is important to distinguish between "NGF is relevant to eye health" and "lion's mane has proven benefits for eye health." The former is established; the latter is not.

Study 1: Erinacine A and Traumatic Optic Neuropathy (The Most Directly Relevant Study)

The most directly relevant study examined erinacine A — a diterpenoid compound from lion's mane mycelium — in a rat model of traumatic optic neuropathy (PMID: 36612613). Traumatic optic neuropathy involves damage to the optic nerve following blunt or penetrating trauma, leading to RGC death and vision loss.

In this study, erinacine A treatment produced significant protective effects:

• The standard-dose group showed a 10.0-fold reduction in apoptotic (dying) retinal ganglion cells compared to untreated injured animals
• The double-dose group showed a 15.6-fold reduction in RGC apoptosis
• Macrophage infiltration on the optic nerve was reduced by 1.8-fold (standard dose) and 2.2-fold (double dose), indicating reduced neuroinflammation
• Visual function was preserved in treated animals as measured by electroretinography

The proposed mechanisms included: suppression of neuroinflammation, reduction of oxidative stress markers, and activation of the Nrf2 antioxidant pathway in optic nerve and cortical tissue.

These results are genuinely interesting. The effect sizes are large. But several critical limitations must be understood:

• This is a single animal study in rats. Animal studies frequently do not translate to humans, particularly for neurological outcomes.
• Traumatic optic neuropathy is a specific acute injury model — it is not a model of glaucoma, age-related macular degeneration, diabetic retinopathy, or any of the common chronic eye conditions affecting most people.
• The compound used was erinacine A from mycelium. Our extract is 100% fruiting body. Erinacine A is not present in meaningful amounts in fruiting body extracts. This is not a minor caveat — it means the mechanism demonstrated in this study does not directly apply to our product.

Study 2: Retinal Neurite Outgrowth in Cell Culture

A 2015 in vitro study (PMID: 26853959) tested lion's mane extract on dissociated cells from rat brain, spinal cord, and retina. The extract stimulated neurite outgrowth in retinal cells — the process by which neurons extend their projections to form connections with other cells.

Neurite outgrowth is relevant to visual function because the retinal circuitry that processes and transmits visual information depends on intact neural connections. Damage to these connections is a feature of several eye conditions, including glaucoma (where RGC axons are progressively lost) and diabetic retinopathy (where neural circuitry in the retina is disrupted alongside vascular changes).

The limitations here are significant: this is a cell culture experiment (not even an animal study), it used an unspecified lion's mane extract, and neurite outgrowth in a dish does not directly predict functional outcomes in the complex environment of a living eye.

Study 3: Ergothioneine and the OCTN1 Eye Connection

Ergothioneine is a naturally occurring amino acid with potent antioxidant properties that is found in particularly high concentrations in lion's mane mushroom — approximately 4.9 mg per gram of dried mushroom (PMID: 37627983). This is substantially higher than most common dietary sources.

What makes ergothioneine relevant to eye health is its transport mechanism. Ergothioneine enters cells exclusively via the OCTN1 (organic cation/carnitine transporter) protein. Research has shown that OCTN1 is expressed at high levels in ocular tissue — particularly in the lens and cornea — meaning these structures actively accumulate ergothioneine from the bloodstream (PMID: 36769554).

The eye is one of the organs most vulnerable to oxidative stress. The lens is continuously exposed to ultraviolet radiation and visible light, generating reactive oxygen species. Oxidative damage to lens proteins is a major contributor to cataract formation. The cornea faces similar oxidative challenges from environmental exposure.

The biological logic is sound: an antioxidant compound that is actively concentrated in the lens and cornea could plausibly offer protection against oxidative damage in these structures. However, this mechanism has not been tested clinically with lion's mane as the source of ergothioneine. The research establishes the pathway (OCTN1 concentrates ergothioneine in eye tissue) but does not establish the clinical outcome (does taking lion's mane meaningfully improve eye health?). That trial has not been conducted.

Our Extract: Fruiting Body, Not Mycelium — Why This Matters for Eye Health

Teelixir's lion's mane is a 10:1 dual-extracted (hot water and ethanol) extract from 100% fruiting body. Our batch C24051507 sourced from Xi'an Lifewe (Yes Herbs, China) tested at 31.7% beta-glucans, passes heavy metal limits (lead ≤3.0 mg/kg, arsenic ≤2.0 mg/kg, cadmium ≤1.0 mg/kg, mercury ≤0.1 mg/kg), and is E. coli and Salmonella negative.

The primary bioactive compounds in the fruiting body are hericenones (C-H series), which stimulate NGF synthesis and cross the blood-brain barrier. These are distinct from erinacines (A-K series), which are found in the mycelium and were used in the traumatic optic neuropathy study.

This is not a trivial distinction for the eye health application. The retinal protection study specifically used erinacine A. Whether hericenones from fruiting body produce equivalent retinal protection is unknown — it is a reasonable hypothesis given both compound families stimulate NGF, but it has not been tested.

What our fruiting body extract does contain that is relevant to eye health:

• Ergothioneine (water-soluble, captured in our hot water extraction phase) — the antioxidant compound with documented accumulation in OCTN1-expressing eye tissue at approximately 4.9 mg/g dried mushroom
• Hericenones (ethanol-soluble, captured in our ethanol extraction phase) — NGF-stimulating compounds that broadly support neural tissue, potentially including optic nerve neurons
• Beta-glucans at 31.7% — immunomodulatory polysaccharides with anti-inflammatory effects relevant to neuroinflammatory pathways

How This Compares to Established Eye Health Supplements

If eye health is your primary concern, the honest comparison is with supplements that have rigorous human evidence. The AREDS2 study (Age-Related Eye Disease Study 2, n=4,203 participants, median follow-up five years) established that a specific combination of lutein (10 mg), zeaxanthin (2 mg), vitamin C (500 mg), vitamin E (400 IU), zinc (80 mg), and copper (2 mg) reduced the risk of progression to advanced age-related macular degeneration (AMD) by 25% compared to placebo.

That is a large, well-designed, multi-year human RCT with a clinically meaningful endpoint. Lion's mane has zero human RCTs for any eye health outcome. The evidence gap is not subtle.

Similarly, omega-3 fatty acids (particularly DHA, which is concentrated in the photoreceptor outer segments of the retina) have extensive research suggests benefits for supporting retinal health and reducing dry eye symptoms.

This does not mean lion's mane has no place in a comprehensive approach to eye health. The neuroprotective mechanisms — particularly ergothioneine accumulation in ocular tissue and broad CNS support via NGF — are biologically plausible additions alongside lutein, zeaxanthin, and omega-3s. But lion's mane should not be positioned as an eye health supplement in the same category as these established options.

Honest Limitations

• Zero human clinical trials exist for any eye health outcome with lion's mane. Every claim in this space is extrapolated from pre-clinical research.
• The most relevant eye study used erinacine A from mycelium (PMID: 36612613), not hericenones from fruiting body. Our product contains fruiting body only — the specific compound tested is not in our extract.
• The traumatic optic neuropathy model does not represent common eye conditions. Glaucoma, AMD, and diabetic retinopathy have different pathophysiology and have not been studied with any form of lion's mane.
• The ergothioneine-OCTN1 connection establishes a plausible mechanism, not a proven clinical outcome. Whether supplementation meaningfully increases ergothioneine levels in human eye tissue has not been tested.
• The AREDS2 nutrient combination has rigorous long-term evidence that lion's mane cannot currently match for macular degeneration specifically.
• No Australian FSANZ permitted health claims exist for lion's mane and vision or eye health.
• No Cochrane systematic review exists on lion's mane and eye health — the evidence base is too sparse to review systematically.

Teelixir Organic Lion's Mane Mushroom

10:1 dual extract · 100% fruiting body · 31.7% beta-glucans · Heavy metal tested

View Product

Where the Research Needs to Go Next

For lion's mane to be meaningfully positioned in eye health, the research gaps are clear. First, human trials are needed — at minimum, pharmacokinetic studies measuring ergothioneine levels in ocular tissue following lion's mane supplementation in humans. Second, fruiting body-specific eye studies are needed — the existing animal evidence uses mycelium erinacine A, not fruiting body hericenones. Third, relevant disease models need to be studied — glaucoma, AMD, and diabetic retinopathy are the conditions of highest public health relevance, and none have been studied with any form of lion's mane.

The 2022 traumatic optic neuropathy study (PMID: 36612613) is a genuine scientific contribution — it demonstrates that a lion's mane compound can reach retinal tissue and produce measurable neuroprotective effects in a living animal. That is a meaningful starting point. But a single pre-clinical study is not a foundation for clinical recommendations, and we will not pretend otherwise.

What to Prioritise While the Evidence Develops

If you are interested in a comprehensive approach to long-term eye health while the lion's mane research matures:

• Lutein and zeaxanthin (10 mg lutein + 2 mg zeaxanthin daily) — strong AREDS2 evidence for macular protection in those at risk of AMD progression
• Omega-3 fatty acids (DHA-rich, 1-2g combined EPA/DHA daily) — evidence for dry eye reduction and general retinal health
• Regular ophthalmological screening — particularly for those over 50, with diabetes, or with family history of glaucoma or AMD
• UV protection — quality sunglasses with UV400 or polarised lenses reduce cumulative photodamage to the lens and retina
• Blood glucose management — diabetic retinopathy is the leading cause of vision loss in working-age Australians; glycaemic control remains the most evidence-based intervention

Lion's mane, taken for its established neuroprotective and cognitive benefits, may offer a complementary contribution to CNS and eye health — but it should be viewed through that lens (pun intended), not as a primary eye health supplement.

For more on what lion's mane actually does well, see our comprehensive benefits guide, the evidence for cognitive protection in seniors, and the ergothioneine and skin health connection — which follows the same OCTN1 tissue-accumulation logic as the eye story.

Frequently Asked Questions

This article is for informational and educational purposes only and does not constitute medical advice. Lion's mane mushroom is a food supplement, not a medicine. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement regimen, particularly if you have an existing eye condition, are pregnant or breastfeeding, or are taking prescribed medication. Individual results may vary.

Continue Your Research

• Lion's Mane for Weight Loss: An Honest Evidence Assessment
• Lion's Mane Dosage Guide: Clinical Trial Doses, Extract Conversions & Timing
• Lion's Mane Side Effects: Safety Profile Review
• Lion's Mane for ADHD and Focus: What the Research Actually Shows
• Lion's Mane for Anxiety: What the Research Actually Shows
• Lion's Mane for Gut Health: The Prebiotic Bridge Your Microbiome Has Been Waiting For
• Lion's Mane vs Ashwagandha: The NGF-Cortisol Effect Explained
• Lion's Mane and Ashwagandha: The Build-and-Protect Stack

← Back to Lion's Mane Research Hub